Caption Management »

ResMed shares owned by Caption Management

Quarter-by-quarter ownership of ResMed (RMD) shares owned by Caption Management from 13F filings

Historical chart of Caption Management investment in ResMed

Tip: Access up to 7 years of quarterly data

All positions including ResMed held by Caption Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ResMed by Caption Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $66M 335k 198.03
2022-03-31 $9.2M 38k 242.47
2020-09-30 $428k 2.5k 171.20

More positions owned by Caption Management

Citigroup Com New Put Option (C)
Verizon Communications Put Option (VZ)
Caterpillar Call Option (CAT)
Sarepta Therapeutics Call Option (SRPT)
Metropcs Communications Call Option (TMUS)
Mondelez Intl Cl A Put Option (MDLZ)
Spdr Ser Tr S&p Regl Bkg Put Option (KRE)
Cytokinetics Com New Call Option (CYTK)
AmerisourceBergen Call Option (COR)
Capri Holdings SHS Call Option (CPRI)
United States Steel Corporation Call Option (X)
Viking Therapeutics Call Option (VKTX)
Alnylam Pharmaceuticals Call Option (ALNY)
Adobe Systems Incorporated Put Option (ADBE)
ResMed Call Option (RMD)

View all positions for Caption Management

Top funds holding ResMed

Vanguard Group
BlackRock
Bank of New York Mellon
Geode Capital Management
Morgan Stanley
FMR
Northern Trust
Jpmorgan Chase & Co
Legal & General Group
Goldman Sachs Group
Charles Schwab Investment Management
Fil
Lgt Capital Partners
Ubs Global Asset Management Americas
Citadel Advisors

View all funds holding ResMed